All In Biotech

Drug Trial Radar · NCT07343245

A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics Drug-Drug Interaction of DW4421 and 3 NSAIDs in Healthy Adult Volunteers

Last checked: Nov 20, 2026Latest source record: Jan 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Dec 1, 2025

Primary completion

Feb 22, 2026

Study completion Jun 17, 2026

Sponsor

Sponsor type
Industry
First posted
Jan 15, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
FDA-regulated drug
No
Who can join
All sexes, from 19 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Drug-Drug Interaction between DW4421 and three different kinds of NSAIDs

Conditions

  • Healthy Adult

Interventions

  • DW4421Drug

    QD

  • DW4421-N1Drug

    BID

  • DW4421-N2Drug

    BID

  • DW4421-N3Drug

    QD

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cmax,ssTime frame: Baseline to Day 13 or Day 15
  2. AUCτ,ssTime frame: Baseline to Day 13 or Day 15

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Chungbuk National University Hospital

    Cheongju-si, South Korea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.